-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WCqRM7JuSO7jtzTkR9eI4BEylSq2rO5SHvJuLOD/PXohw5o2BnTcU33W6yGeZdTy 5m9Ml7zTVo5O6pFktILQyA== 0001127602-10-008867.txt : 20100316 0001127602-10-008867.hdr.sgml : 20100316 20100316190555 ACCESSION NUMBER: 0001127602-10-008867 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100315 FILED AS OF DATE: 20100316 DATE AS OF CHANGE: 20100316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOROVITZ ZOLA P CENTRAL INDEX KEY: 0001033507 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 10687054 MAIL ADDRESS: STREET 1: C/O GENAERA CORP STREET 2: 5110 CAMPUS DDRIVE CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-03-15 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001033507 HOROVITZ ZOLA P 2190 PARKWAY LAKE DRIVE BIRMINGHAM AL 35244- 1 Common Stock 2010-03-15 4 M 0 10000 2.60 A 13000 D Common Stock 2010-03-15 4 S 0 10000 7.215 D 3000 D Stock Option (Right to Buy) 2.60 2010-03-15 4 M 0 10000 0 D 2004-05-14 2013-05-14 Common Stock 10000 0 D Transacted under a 10b5-1 plan that was adopted on 11/24/2009. The price in column 4 is a weighted average price. The prices actually ranged from $7.11 to $7.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. /s/ Michael Richardson, by power of attorney 2010-03-16 -----END PRIVACY-ENHANCED MESSAGE-----